Members only Journal Clubs FLOW Trial Journal Club We break down evidence-based medicine so you don't have to! This journal club will discuss the new FLOW trial that has some landmark results you don't want to miss!
Paid-members only Clinical Pharmacy REDUCE-AMI Journal Club We break down evidence-based medicine so you don't have to! This journal club will discuss the new REDUCE-AMI trial that is hot in the cardiology literature right now.
Clinical Pharmacy Should Clinical Trial Results Expire? REDUCE-AMI Study The findings of this study were rather damning. In essence, the study found NO BENEFIT from adding long-term beta-blocker treatment in patients with acute myocardial infarction (MI) who have a preserved ejection fraction.
Clinical Pharmacy Lessons Learned from the ACCOMPLISH and ALLHAT Trials Today we will discuss the ACCOMPLISH Trial from 2008 and ALLHAT Trial from 2002. Yes, a trial from over 20 years ago. Why are we bringing these back to the limelight? I wanted to review these trials specifically to show you that not all first-line guideline-recommended therapies are the same.
Clinical Pharmacy DELIVER Trial The New England Journal of Medicine published the DELIVER trial at the end of August 2022. This post is going to be a journal club breaking down the DELIVER trial and what change it may bring to our clinical practice.
Clinical Pharmacy MANDALA Trial The New England Journal of Medicine published the MANDALA trial online in May 2022. This post is going to be a journal club breaking down the MANDALA trial and what change it may bring to our clinical practice.